Luse Rebecca
SEC insider (Form 3/4/5 filer). CIK 0002031342. Director at LB PHARMACEUTICALS INC (LBRX). 2 reported Form 4/5 transactions since Sep 2024; latest on Jun 3, 2026. Located in NEW YORK, NY.
Companies Luse Rebecca has filed insider reports for
- LB PHARMACEUTICALS INC (LBRX): Director
Luse Rebecca
CIK: 0002031342
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
LBRX
LB PHARMACEUTICALS INC
Director